These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20048213)

  • 1. Endogenous erythropoietin and outcome in heart failure.
    Belonje AM; Voors AA; van der Meer P; van Gilst WH; Jaarsma T; van Veldhuisen DJ
    Circulation; 2010 Jan; 121(2):245-51. PubMed ID: 20048213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.
    van der Meer P; Lok DJ; Januzzi JL; de la Porte PW; Lipsic E; van Wijngaarden J; Voors AA; van Gilst WH; van Veldhuisen DJ
    Eur Heart J; 2008 Jun; 29(12):1510-5. PubMed ID: 18495690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
    van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure.
    Peterson PN; Magid DJ; Lyons EE; Clarke CL; Zeng C; Fitzgerald A; Lindenfeld J; Kosiborod M; Brand D; Masoudi FA
    Am Heart J; 2010 Jan; 159(1):81-9. PubMed ID: 20102871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
    George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G
    Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
    Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
    Ralli S; Horwich TB; Fonarow GC
    Am Heart J; 2005 Dec; 150(6):1220-7. PubMed ID: 16338262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure.
    Florea VG; Henein MY; Anker SD; Francis DP; Chambers JS; Ponikowski P; Coats AJ
    Eur Heart J; 2000 Jan; 21(2):146-53. PubMed ID: 10637088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.
    Frasure-Smith N; Lespérance F; Habra M; Talajic M; Khairy P; Dorian P; Roy D;
    Circulation; 2009 Jul; 120(2):134-40, 3p following 140. PubMed ID: 19564557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study.
    Baggish AL; van Kimmenade R; Bayes-Genis A; Davis M; Lainchbury JG; Frampton C; Pinto Y; Richards MA; Januzzi JL
    Clin Chim Acta; 2007 Jun; 381(2):145-50. PubMed ID: 17445789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, prognostic importance and therapeutic implications of anemia in heart failure.
    Mishra TK; Mishra SK; Mohanty NK; Rath PK
    Indian Heart J; 2005; 57(6):670-4. PubMed ID: 16521636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT.
    Anand IS; Kuskowski MA; Rector TS; Florea VG; Glazer RD; Hester A; Chiang YT; Aknay N; Maggioni AP; Opasich C; Latini R; Cohn JN
    Circulation; 2005 Aug; 112(8):1121-7. PubMed ID: 16103233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
    Belonje AM; Westenbrink BD; Voors AA; von Haehling S; Ponikowski P; Anker SD; van Veldhuisen DJ; Dickstein K
    Am Heart J; 2009 Jan; 157(1):91-6. PubMed ID: 19081402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life expectancy after an index hospitalization for patients with heart failure: a population-based study.
    Ko DT; Alter DA; Austin PC; You JJ; Lee DS; Qiu F; Stukel TA; Tu JV
    Am Heart J; 2008 Feb; 155(2):324-31. PubMed ID: 18215604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.